[go: up one dir, main page]

UA108688C2 - 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents - Google Patents

2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents

Info

Publication number
UA108688C2
UA108688C2 UAA201310452A UAA201310452A UA108688C2 UA 108688 C2 UA108688 C2 UA 108688C2 UA A201310452 A UAA201310452 A UA A201310452A UA A201310452 A UAA201310452 A UA A201310452A UA 108688 C2 UA108688 C2 UA 108688C2
Authority
UA
Ukraine
Prior art keywords
trimethoxyphenyl
ylthio
triazol
acetate acid
antioxidant agents
Prior art date
Application number
UAA201310452A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрій Геннадійович Самелюк
Андрій Григорович Каплаушенко
Віктор Дмитрович Лук'янчук
Original Assignee
Запорізький Державний Медичний Університет
Юрій Геннадійович Самелюк
Андрій Григорович Каплаушенко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Запорізький Державний Медичний Університет, Юрій Геннадійович Самелюк, Андрій Григорович Каплаушенко filed Critical Запорізький Державний Медичний Університет
Priority to UAA201310452A priority Critical patent/UA108688C2/en
Publication of UA108688C2 publication Critical patent/UA108688C2/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The object of the invention: 2-(5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents. Application area: pharmacy, medicine, veterinary medicine. Summary: 2-(5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazol-3-ylthio) acetate acid contains at N2-core of the atome of the 1,2,4-triazole amino group, in the 5-position of the 1,2,4-triazole nucleus it contains 3,4,5-trimethoxyphenyl radical, and also incorporates a divalent sulfur atom. Technical result: the ability to inhibit free radical oxidation processes, moderate solubility and storage stability, simple preparation procedure, reagents availability for synthesis.
UAA201310452A 2013-08-27 2013-08-27 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents UA108688C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201310452A UA108688C2 (en) 2013-08-27 2013-08-27 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201310452A UA108688C2 (en) 2013-08-27 2013-08-27 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents

Publications (1)

Publication Number Publication Date
UA108688C2 true UA108688C2 (en) 2015-05-25

Family

ID=53674988

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201310452A UA108688C2 (en) 2013-08-27 2013-08-27 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents

Country Status (1)

Country Link
UA (1) UA108688C2 (en)

Similar Documents

Publication Publication Date Title
CU24462B1 (en) DERIVATIVES OF PHENYLTRIAZOLE SUBSTITUTED WITH HYDROXYALKYL
BR112015000160A2 (en) Manufacture of 2- (5-bromo-4- (4-cyclopropylhydronaphthalen-1-yl) -4h-1,2,4-triazol-3-yl-thio) acetic acid
CU20180134A7 (en) PIRIDINILTRIAZOL DERIVATIVES SUBSTITUTED WITH AMIDA USEFUL TO TREAT RENAL AND CARDIOVASCULAR DISEASES
MY192521A (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
MA44820B1 (en) Heterocyclic amides for use as kinase inhibitors
EP2883875A4 (en) DERIVED FROM N2, N4-BIS (4- (PIPERAZIN-1-YL) PHENYL) PIRIMIDINE-2,4-DIAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING THE SAME AS ACTIVE SUBSTANCE FOR PREVENTING OR TREATING CANCER
RS54492B1 (en) Apoptosis signal-regulating kinase inhibitor
JO3392B1 (en) Aromatic heterocyclic compounds as antiinflammatory compounds
GEP201706778B (en) Pyridinyl and fused pyridinyl triazolone derivatives
EA201590854A1 (en) Pyridine-2-amides, suitable as agonists of cannabinoid receptor 2
PH12016500885A1 (en) Novel heterocyclic compounds
EP2560642A4 (en) Treatment of gout
NZ629636A (en) Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
EA201692270A1 (en) DERIVATIVES OF NAFTYRIDINDIONE
MY174648A (en) Formulations of organic compounds
AR086803A1 (en) DERIVATIVES OF OXAZETIDINES, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT DERMATOLOGIC DISEASES FUNDAMENTALLY, AND THE RESPIRATORY, DIGESTIVE AND CARDIOVASCULAR, BETWEEN OTHER
PH12016500134B1 (en) 1-(piperazin-1-yl) -2- ([1,2,4] triazol -1- yl) - ethanone derivatives
EP3004085A4 (en) IMIDAZOLE DERIVATIVES AND METHODS OF USE FOR ENHANCING THE PHARMACOKINETICS OF A MEDICAMENT
MD4215B1 (en) Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide
UA108688C2 (en) 2-(5-(3,4,5-trimethoxyphenyl)-1h-1,2,4-triazol-3-ylthio) acetate acid as the antioxidant agents
CY1120933T1 (en) CRYSTAL OF BENZOLIE PRODUCER AZOL AS XANTHIN OXIDATION INHIBITOR
MD20110040A1 (en) Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate
UA108689C2 (en) 2-(4-amino-5- (4-nitrophenyl)-4h-1,2,4-triazol-3-ylthio) acetate acid as antioxidant agent
BR112015003281A2 (en) diazepinone derivatives useful for the treatment of fragile x syndrome, parkinson's disease or reflux
UA109385C2 (en) Ferrum(ii)-2-(5-(phenoxymethyl)-4-phenyl-1,2,4- triazol-3-ylthio)acetate exhibiting actoprotector activity